|
Gene: SERPINF2 |
Gene summary for SERPINF2 |
Gene summary. |
Gene information | Species | Human | Gene symbol | SERPINF2 | Gene ID | 5345 |
Gene name | serpin family F member 2 | |
Gene Alias | A2AP | |
Cytomap | 17p13.3 | |
Gene Type | protein-coding | GO ID | GO:0000165 | UniProtAcc | P08697 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
5345 | SERPINF2 | P74T-E | Human | Esophagus | ESCC | 3.08e-19 | 5.83e-01 | 0.1479 |
5345 | SERPINF2 | P75T-E | Human | Esophagus | ESCC | 5.71e-06 | 4.74e-02 | 0.1125 |
5345 | SERPINF2 | P76T-E | Human | Esophagus | ESCC | 2.02e-03 | 1.06e-01 | 0.1207 |
5345 | SERPINF2 | P128T-E | Human | Esophagus | ESCC | 1.17e-15 | 4.23e-01 | 0.1241 |
5345 | SERPINF2 | P130T-E | Human | Esophagus | ESCC | 9.84e-31 | 6.87e-01 | 0.1676 |
5345 | SERPINF2 | NAFLD1 | Human | Liver | NAFLD | 7.93e-10 | 8.58e-01 | -0.04 |
5345 | SERPINF2 | S43 | Human | Liver | Cirrhotic | 2.66e-05 | 4.06e-02 | -0.0187 |
5345 | SERPINF2 | HCC1_Meng | Human | Liver | HCC | 3.62e-74 | 1.69e-01 | 0.0246 |
5345 | SERPINF2 | HCC2_Meng | Human | Liver | HCC | 4.29e-05 | -2.19e-01 | 0.0107 |
5345 | SERPINF2 | HCC1 | Human | Liver | HCC | 1.36e-45 | 6.30e+00 | 0.5336 |
5345 | SERPINF2 | HCC2 | Human | Liver | HCC | 2.98e-32 | 5.24e+00 | 0.5341 |
5345 | SERPINF2 | Pt14.a | Human | Liver | HCC | 1.70e-08 | 5.30e-01 | 0.0169 |
5345 | SERPINF2 | Pt14.b | Human | Liver | HCC | 2.19e-12 | 4.57e-01 | 0.018 |
5345 | SERPINF2 | S014 | Human | Liver | HCC | 5.59e-22 | 1.46e+00 | 0.2254 |
5345 | SERPINF2 | S015 | Human | Liver | HCC | 3.67e-24 | 1.89e+00 | 0.2375 |
5345 | SERPINF2 | S016 | Human | Liver | HCC | 4.98e-27 | 1.21e+00 | 0.2243 |
5345 | SERPINF2 | S028 | Human | Liver | HCC | 1.04e-09 | 6.64e-01 | 0.2503 |
5345 | SERPINF2 | S029 | Human | Liver | HCC | 2.18e-11 | 8.05e-01 | 0.2581 |
Page: 1 2 |
Transcriptomic changes along malignancy continuum. |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | |
Colorectum | SER | |
Colorectum | MSS | |
Colorectum | MSI-H | |
Colorectum | FAP |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:1902905111 | Esophagus | ESCC | positive regulation of supramolecular fiber organization | 142/8552 | 209/18723 | 5.51e-11 | 1.76e-09 | 142 |
GO:005160418 | Esophagus | ESCC | protein maturation | 189/8552 | 294/18723 | 7.64e-11 | 2.39e-09 | 189 |
GO:1902903111 | Esophagus | ESCC | regulation of supramolecular fiber organization | 237/8552 | 383/18723 | 9.06e-11 | 2.75e-09 | 237 |
GO:0052547111 | Esophagus | ESCC | regulation of peptidase activity | 275/8552 | 461/18723 | 7.54e-10 | 1.88e-08 | 275 |
GO:005149520 | Esophagus | ESCC | positive regulation of cytoskeleton organization | 147/8552 | 226/18723 | 2.93e-09 | 6.38e-08 | 147 |
GO:000701527 | Esophagus | ESCC | actin filament organization | 259/8552 | 442/18723 | 2.37e-08 | 4.50e-07 | 259 |
GO:0052548111 | Esophagus | ESCC | regulation of endopeptidase activity | 253/8552 | 432/18723 | 3.68e-08 | 6.78e-07 | 253 |
GO:004578527 | Esophagus | ESCC | positive regulation of cell adhesion | 255/8552 | 437/18723 | 5.07e-08 | 9.11e-07 | 255 |
GO:003109818 | Esophagus | ESCC | stress-activated protein kinase signaling cascade | 154/8552 | 247/18723 | 8.53e-08 | 1.44e-06 | 154 |
GO:0032970111 | Esophagus | ESCC | regulation of actin filament-based process | 231/8552 | 397/18723 | 2.91e-07 | 4.20e-06 | 231 |
GO:0032956111 | Esophagus | ESCC | regulation of actin cytoskeleton organization | 210/8552 | 358/18723 | 4.40e-07 | 6.00e-06 | 210 |
GO:004206027 | Esophagus | ESCC | wound healing | 243/8552 | 422/18723 | 4.62e-07 | 6.25e-06 | 243 |
GO:005140318 | Esophagus | ESCC | stress-activated MAPK cascade | 147/8552 | 239/18723 | 5.43e-07 | 7.18e-06 | 147 |
GO:011005327 | Esophagus | ESCC | regulation of actin filament organization | 166/8552 | 278/18723 | 1.54e-06 | 1.85e-05 | 166 |
GO:005101727 | Esophagus | ESCC | actin filament bundle assembly | 100/8552 | 157/18723 | 3.87e-06 | 4.17e-05 | 100 |
GO:006157227 | Esophagus | ESCC | actin filament bundle organization | 101/8552 | 161/18723 | 9.22e-06 | 8.82e-05 | 101 |
GO:007030217 | Esophagus | ESCC | regulation of stress-activated protein kinase signaling cascade | 119/8552 | 195/18723 | 1.07e-05 | 1.01e-04 | 119 |
GO:001648514 | Esophagus | ESCC | protein processing | 134/8552 | 225/18723 | 1.81e-05 | 1.60e-04 | 134 |
GO:003287217 | Esophagus | ESCC | regulation of stress-activated MAPK cascade | 116/8552 | 192/18723 | 2.63e-05 | 2.21e-04 | 116 |
GO:00072549 | Esophagus | ESCC | JNK cascade | 102/8552 | 167/18723 | 4.22e-05 | 3.39e-04 | 102 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa04610 | Liver | NAFLD | Complement and coagulation cascades | 35/1043 | 86/8465 | 2.48e-11 | 2.04e-09 | 1.64e-09 | 35 |
hsa046101 | Liver | NAFLD | Complement and coagulation cascades | 35/1043 | 86/8465 | 2.48e-11 | 2.04e-09 | 1.64e-09 | 35 |
hsa046102 | Liver | Cirrhotic | Complement and coagulation cascades | 48/2530 | 86/8465 | 4.41e-07 | 5.44e-06 | 3.35e-06 | 48 |
hsa046103 | Liver | Cirrhotic | Complement and coagulation cascades | 48/2530 | 86/8465 | 4.41e-07 | 5.44e-06 | 3.35e-06 | 48 |
hsa046104 | Liver | HCC | Complement and coagulation cascades | 57/4020 | 86/8465 | 3.19e-04 | 1.45e-03 | 8.04e-04 | 57 |
hsa046105 | Liver | HCC | Complement and coagulation cascades | 57/4020 | 86/8465 | 3.19e-04 | 1.45e-03 | 8.04e-04 | 57 |
Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SERPINF2 | SNV | Missense_Mutation | c.743N>A | p.Ser248Asn | p.S248N | P08697 | protein_coding | tolerated(0.16) | benign(0.001) | TCGA-A8-A08R-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
SERPINF2 | SNV | Missense_Mutation | c.611T>C | p.Ile204Thr | p.I204T | P08697 | protein_coding | deleterious(0.04) | probably_damaging(1) | TCGA-BH-A1FL-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
SERPINF2 | SNV | Missense_Mutation | novel | c.1311N>G | p.Asn437Lys | p.N437K | P08697 | protein_coding | deleterious(0) | possibly_damaging(0.72) | TCGA-E2-A576-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | taxotere | SD |
SERPINF2 | insertion | Nonsense_Mutation | novel | c.1028_1029insATACACACAACATAAAAAAGTTACTGAGAACTCTTCTTAGT | p.His343GlnfsTer14 | p.H343Qfs*14 | P08697 | protein_coding | TCGA-BH-A0B4-01 | Breast | breast invasive carcinoma | Male | >=65 | III/IV | Hormone Therapy | tamoxiphen | SD | ||
SERPINF2 | insertion | Frame_Shift_Ins | novel | c.1330_1331insCTCGCTGGCTTCCCTGGAAGGGGAAGGAGGAGAAGCTGGGG | p.Leu444ProfsTer31 | p.L444Pfs*31 | P08697 | protein_coding | TCGA-BH-A0HQ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | arimidex | SD | ||
SERPINF2 | SNV | Missense_Mutation | novel | c.229N>A | p.Glu77Lys | p.E77K | P08697 | protein_coding | tolerated(0.36) | benign(0.014) | TCGA-4J-AA1J-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
SERPINF2 | SNV | Missense_Mutation | rs121965062 | c.1231N>A | p.Val411Met | p.V411M | P08697 | protein_coding | tolerated(0.07) | benign(0.409) | TCGA-EA-A410-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
SERPINF2 | SNV | Missense_Mutation | c.1214C>T | p.Ser405Phe | p.S405F | P08697 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-JW-A5VJ-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | PD | |
SERPINF2 | SNV | Missense_Mutation | rs376458796 | c.1171G>A | p.Val391Met | p.V391M | P08697 | protein_coding | deleterious(0.03) | probably_damaging(0.995) | TCGA-5M-AAT6-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Unknown | Unknown | PD |
SERPINF2 | SNV | Missense_Mutation | c.1306N>A | p.Pro436Thr | p.P436T | P08697 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-A6-5665-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |